Managed Asset Portfolios’s Takeda Pharmaceutical TAK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $23M | Buy |
1,488,843
+19,177
| +1% | +$296K | 2.99% | 15 |
|
|
2025
Q1 | $21.9M | Buy |
1,469,666
+52,218
| +4% | +$776K | 3.03% | 13 |
|
|
2024
Q4 | $18.8M | Sell |
1,417,448
-200,093
| -12% | -$2.65M | 2.78% | 16 |
|
|
2024
Q3 | $23M | Buy |
1,617,541
+4,069
| +0.3% | +$57.9K | 3.25% | 14 |
|
|
2024
Q2 | $20.9M | Sell |
1,613,472
-70,204
| -4% | -$908K | 3.1% | 16 |
|
|
2024
Q1 | $23.4M | Sell |
1,683,676
-74,405
| -4% | -$1.03M | 3.4% | 13 |
|
|
2023
Q4 | $25.1M | Buy |
1,758,081
+21,665
| +1% | +$309K | 3.8% | 9 |
|
|
2023
Q3 | $26.9M | Buy |
1,736,416
+25,291
| +1% | +$391K | 4.12% | 7 |
|
|
2023
Q2 | $26.9M | Buy |
1,711,125
+243,173
| +17% | +$3.82M | 4.04% | 8 |
|
|
2023
Q1 | $24.2M | Sell |
1,467,952
-1,476
| -0.1% | -$24.3K | 3.67% | 11 |
|
|
2022
Q4 | $22.9M | Buy |
1,469,428
+7,614
| +0.5% | +$119K | 3.58% | 11 |
|
|
2022
Q3 | $19M | Buy |
1,461,814
+17,013
| +1% | +$221K | 3.36% | 11 |
|
|
2022
Q2 | $20.3M | Buy |
1,444,801
+44,923
| +3% | +$631K | 3.22% | 15 |
|
|
2022
Q1 | $20M | Buy |
1,399,878
+233,850
| +20% | +$3.35M | 2.75% | 19 |
|
|
2021
Q4 | $15.9M | Sell |
1,166,028
-49,721
| -4% | -$678K | 2.25% | 21 |
|
|
2021
Q3 | $19.9M | Buy |
1,215,749
+9,561
| +0.8% | +$157K | 3.03% | 17 |
|
|
2021
Q2 | $20.3M | Buy |
1,206,188
+140,432
| +13% | +$2.36M | 3.02% | 17 |
|
|
2021
Q1 | $19.5M | Buy |
1,065,756
+99,113
| +10% | +$1.81M | 3.13% | 16 |
|
|
2020
Q4 | $17.6M | Buy |
966,643
+54,659
| +6% | +$995K | 3.09% | 16 |
|
|
2020
Q3 | $16.3M | Buy |
911,984
+327,808
| +56% | +$5.85M | 3.24% | 16 |
|
|
2020
Q2 | $10.5M | Buy |
584,176
+274,901
| +89% | +$4.93M | 2.27% | 21 |
|
|
2020
Q1 | $4.7M | Buy |
+309,275
| New | +$4.7M | 1.25% | 21 |
|